Metoclopramide and Malignant neoplasm progression - a phase IV clinical study of FDA data
Summary:
Malignant neoplasm progression is reported as a side effect among people who take Metoclopramide (metoclopramide hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Ondansetron, and have Pain.
The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Metoclopramide. It is created by eHealthMe based on reports of 80,804 people who have side effects when taking Metoclopramide from the FDA, and is updated regularly.
What is Metoclopramide?
Metoclopramide has active ingredients of metoclopramide hydrochloride. It is often used in nausea. eHealthMe is studying from 81,263 Metoclopramide users. Check the latest studies of Metoclopramide.
What is Malignant neoplasm progression?
Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,516 drugs and 1,634 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.
80,804 people reported to have side effects when taking Metoclopramide.
Among them, 869 people (1.08%) have Malignant neoplasm progression.
Among these 869 people:
How long have people been on Metoclopramide when they have Malignant neoplasm progression? *
What is the gender of people who have Malignant neoplasm progression when taking Metoclopramide? *
What is the age of people who have Malignant neoplasm progression when taking Metoclopramide? *
What are other drugs people take besides Metoclopramide? *
What are other side effects people have besides Malignant neoplasm progression? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Metoclopramide and have Malignant neoplasm progression?
- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Metoclopramide:
- Metoclopramide (81,263 reports)
Malignant neoplasm progression treatments and more:
- Malignant neoplasm progression (107,528 reports)
How severe was Malignant neoplasm progression and when was it recovered:
Expand to all the drugs that have ingredients of metoclopramide hydrochloride:
- Malignant neoplasm progression and drugs with ingredients of metoclopramide hydrochloride (1,178 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Metoclopramide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,516 drugs)
Browse all the conditions that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,634 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Metoclopramide) and Metoclopramide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Anoro Ellipta cause Weight Loss? - 5 seconds ago
- Drug interactions of Bisoprolol Fumarate and Omeprazole - 8 seconds ago
- Could Spironolactone cause Muscle Twitching? - 17 seconds ago
- Drug interactions of Glipizide and Camptosar - 22 seconds ago
- Could Diclofenac cause Ear Pain? - 26 seconds ago
- Could Finasteride cause Swelling? - 44 seconds ago
- Drug interactions of Verapamil Hcl and Buspirone Hcl - 59 seconds ago
- Could Vraylar cause Fainting? - a minute ago
- Could Alphagan P cause Dyspnea? - a minute ago
- Could Vitamin D3 cause Flushing Aggravated? - a minute ago